A carregar...
Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
Temozolomide is the current first-line treatment for glioblastoma patients but, because many patients are resistant to it, there is an urgent need to develop antitumor agents to treat temozolomide-resistant glioblastoma. Gossypol, a natural polyphenolic compound, has been studied as a monotherapy or...
Na minha lista:
| Publicado no: | Biomolecules |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6843396/ https://ncbi.nlm.nih.gov/pubmed/31658771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom9100595 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|